Transcript
Global Anticonvulsants Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2016 – 2026
Future Market Insights
www.futuremarketinsights.com
[email protected]
Report Description Report Description Anticonvulsants, also commonly known as antiepileptic drugs or antiseizure drugs are a diverse group of pharmacology agents used in the treatment of epileptic seizures. Epilepsy is a chronic disorder resulting in repeated and unprovoked seizures. Epileptic seizures are commonly referred as convulsions. Anticonvulsants are mainly used for treatment of epileptic seizures. Epileptic seizures are caused by disturbance in the electrical activity of the brain. In addition, anticonvulsants are also used in treatment of bipolar disorder and in neuropathic pain management. Anyone could potentially have a single epileptic seizure at some point in their lives. This is not the same as having epilepsy, which is a tendency to have seizures that start in the brain. Epilepsy can affect people of any age group. Though brain injury, brain cancer, drug and alcohol misuse and stroke are some of the reasons for epileptic seizures, the exact reason for convulsions is not known. Some of the common symptoms which occur before convulsions include, visual loss, strange feeling, nausea, numbness in body parts, headache and racing thoughts. Anticonvulsants Market: Drivers and Restraints Increasing awareness about the anticonvulsants available in the market, patent expiration of many blockbuster drugs are some of the major factors that are driving the global anticonvulsants market towards growth. There are now 24 antiepileptic drugs (AEDs) approved for use in epilepsy in the US by FDA. Moreover, three trends involving consumption of AEDs have become clinically important and must be considered by all who treat patients with epilepsy.
Report Description Report Description These trends include issues of generic substitution of AEDs, pharmacogenomics predicting serious adverse events in certain ethnic populations, and the issue of the suicide risk involving the entire class of AEDs. While, high costs and unavailability of convenient dosage forms of both generic and branded anticonvulsants are restraining the growth of novel therapies in the anticonvulsants market. Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb1337 Anticonvulsants Market: Segmentation Anticonvulsants market is segmented based on product type, application, end user and geography. Based on product type, the anticonvulsants market is segmented as follows: • Barbiturates • Aldehydes • Benzodiazepines • Aromatic allylic alcohols • Carboxamides • Bromides • Carbamates • Sulfonamides
Report Description Report Description • • • • • • • • • • • •
Fructose derivatives Pyrrolidines Triazines Fatty acids Oxazolidinediones Ureas GABA analogs Propionates Hydantoins Pyrimidinediones Valproylamides (amide derivatives of valproate) Others
Based on application, the anticonvulsants market is segmented as follows: • Epilepsy • Fibromyalgia • Migraine • Neuropathic pain • Bipolar disorder • Anxiety • Borderline personality disorder
Report Description Report Description Based on end user, the anticonvulsants market is segmented as follows: • Hospitals • Clinics • Ambulatory surgical clinics
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1337 Anticonvulsants Market: Overview Seizures are expected to result in physical, psychological and social repercussions. People with epilepsy could adhere rigorously to their medication regimes in order to prevent these deleterious outcomes. Treatment of epileptic seizures has led to the growth of anticonvulsants market. Barbiturates were the first antiepileptic drugs. These are more effective and tolerable than bromides. Hydantoins are the first to be known as modern antiepileptic drugs. Succinimides are an old group of drug which are rarely prescribed nowadays. Consequently with these antiepileptic or antiseizure drugs, anticonvulsants market is growing immensely leaving a significant impact on the treatment of epileptic seizures. The antiepileptic drug market is threatened by generic completion, which has been increasing dramatically in the face of patent expirations among several of the major branded antiepileptics. However, there have been cases where generic antiepileptic drugs have not been as efficacious as their branded counterparts have.
Report Description Report Description Anticonvulsants Market: Region-wise Outlook Region wise, the global anticonvulsants marketis classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Currently, North America dominates the anticonvulsants market followed by Europe. Asia-Pacific is expected to emerge as a lucrative region, owing to factors such as increasing healthcare spending, improving healthcare infrastructure, and increasing demand for drugs. Given these factors, the market for anticonvulsants is likely to grow rapidly in Asia-Pacific region. Full Report Analysis@ http://www.futuremarketinsights.com/reports/anticonvulsants-market
Anticonvulsants Market: Key Players Some of the key players, contributing to global anticonvulsants drug market, are Johnson & Johnson (J&J), Novartis AG, UCB Group, GlaxoSmithKline plc, Pfizer Inc., Abbott Laboratories, Cephalon Inc. and Shire plc. Pfizer has been estimated to cover the largest market share in the antiepileptic market, accounting for close to one-third of total revenues of the market with it two leading brands.
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client.
Research Capabilities
Customized Research Syndicated Research Investment Research Social Media Research
Sector Coverage
Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Healthcare, Pharmaceuticals & Medical Devices
Customized Research
Subscription Information
Syndicated Research
For detailed subscription information please contact
Investment Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media Research
Hari. T (Sr. Manager - Global Business Development)
Email:
[email protected]
Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas
Thank You!
To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on:
[email protected] For other queries contact: Mr. Sudip Saha Future Market Insights: 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States
